SpyBiotech
SpyBiotech is a clinical-stage biotechnology company that utilizes a proprietary protein superglue technology, SpyTag/SpyCatcher, to develop vaccines. The company focuses on creating preventative and therapeutic treatments for infectious diseases and cancer. Its current pipeline includes a Phase I trial candidate targeting Human Cytomegalovirus (HCMV).
Visit websiteOxford, UK
Biotechnology
Healthcare
Vaccines
Funding summary
- Total raised
- €31.5M
- Funding rounds
- 2
Investors in SpyBiotech
Investors on record for SpyBiotech. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like SpyBiotech?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors